Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B-CLL: implications for rituximab resistance in CLL. [electronic resource]
Producer: 20150610Description: 211-8 p. digitalISSN:- 1365-2141
- Antibodies, Monoclonal, Murine-Derived -- pharmacology
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Antigens, CD20 -- genetics
- Antineoplastic Agents -- pharmacology
- Apoptosis
- CD59 Antigens -- genetics
- Cell Communication
- Coculture Techniques
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Gene Expression
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Mesenchymal Stem Cells -- drug effects
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.